Press Release Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia 8 May 2024
Press Release ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture 8 May 2024
Press Release Franklin BSP Capital Corporation Announces Second Quarter 2024 Regular and Special Common Stock Distribution of $0.33 Per Share 8 May 2024
